UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): November 14, 2019
GWG Holdings, Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 001-36615 | 26-2222607 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) | ||
| 220 South Sixth Street, Suite 1200, Minneapolis, MN | 55402 | |||
| (Address of principal executive offices) | (Zip Code) | |||
(612) 746-1944
(Registrant's telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| Common Stock | GWGH | NASDAQ Capital Market |
| Item 2.02 | Results of Operations and Financial Condition |
On November 14, 2019, GWG Holdings, Inc. issued a press release reporting the financial results for its third fiscal quarter ended September 30, 2019. The full text of the press release is furnished as Exhibit 99.1 to this Form 8-K.
The information in this Current Report on Form 8-K, including the information contained in the press release furnished as Exhibit 99.1, is deemed to be “furnished” and not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is not otherwise subject to the liabilities of that Section, and shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
| Exhibit No. | Description | |
| 99.1 | Press release dated November 14, 2019 (filed herewith) |
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| GWG Holdings, Inc. | ||
| Date: November 14, 2019 | By: | /s/ Timothy L. Evans |
| Timothy L. Evans Chief Financial Officer | ||
2
EXHIBIT INDEX
| Exhibit No. | Description | |
| 99.1 | Press release dated November 14, 2019 (filed herewith) |
3
Exhibit 99.1
GWG HOLDINGS, Inc. ReportS Results for THE THIRD Quarter ENDED
SEPTEMBER 30, 2019
MINNEAPOLIS, MN – November 14, 2019 – GWG Holdings, Inc. (Nasdaq: GWGH), a financial services holding company committed to transforming the alternative asset industry through innovative liquidity products and related services for the owners of illiquid alternative investments, today announced its financial and operating results for the third quarter ended September 30, 2019.
Third Quarter 2019 Financial and Operating Highlights
| · | Reported continued record realizations from our portfolio of life insurance: |
| o | Realized $27.5 million of face amount of policy benefits from 22 life insurance policies during the quarter. |
| o | Reported additional policy realizations of $14.5 million from twelve policies through November 14, 2019. |
| o | Total 2019 year-to-date realizations of $95.5 million from 73 policies – compared to $71.1 million from 62 policies for the entire year of 2018. |
| o | Ended the quarter with a life insurance portfolio of $2.06 billion in face amount of policy benefits consisting of 1,174 policies. |
| · | Reported continued success raising capital to fund our business through the L Bond investment product: |
| o | Restarted sales of L Bonds in early August. |
| o | Experienced consistent near record levels of demand since the restart with combined L Bond sales for August and September of $107 million. |
| o | Hired five new sales executives with strong experience in the sales and marketing of alternative investments. |
| · | Began the process of separating the Company’s insurance technology subsidiaries, Life Epigenetics Inc. and YouSurance General Agency, LLC by contributing these subsidiaries to a newly formed limited liability company InsurTech Holdings, LLC, which is a subsidiary of GWGH and managed by InsurTech Management, LLC, a company controlled by Jon Sabes, former President and Chief Executive Officer of GWGH. |
| · | Reported the inclusion of GWGH in the Russell 2000 Index, the well-known index of small-cap stocks. |
| · | Reported total liquidity (cash, restricted cash and policy benefits receivable) of $144.7 million at November 12, 2019. |
“We believe we have put in place many of the key elements we need to successfully execute our strategy of providing products and services to the vast market of owners who hold illiquid alternative investments,” said Murray Holland, GWGH’s Chief Executive Officer. “We look forward to leveraging the best of GWGH and The Beneficient Company Group, L.P. to create a successful model that serves the growing market of investors who need liquidity.”
1
| 1. | Financial & Operating Highlights |
| ($ Thousands except per share information) | Q3 2019 | Q3 2018 | YTD Q3 2019 | YTD Q3 2018 | ||||||||||||
| Revenue | $ | 22,211 | $ | 20,937 | $ | 71,438 | $ | 59,794 | ||||||||
| Expenses | 43,570 | 31,459 | 127,415 | 79,551 | ||||||||||||
| Per Share Data1: | ||||||||||||||||
| Net Income (Loss)2 | (0.75 | ) | (2.52 | ) | (2.09 | ) | (5.50 | ) | ||||||||
| Capital Raised (L Bonds) | 107,012 | 68,884 | 278,239 | 166,082 | ||||||||||||
| Liquidity3, | 91,254 | 131,416 | 91,254 | 131,416 | ||||||||||||
| Life Insurance Portfolio4 | 2,064,156 | 1,961,598 | 2,064,156 | 1,961,598 | ||||||||||||
| Life Insurance Acquired4 | 3,155 | 120,430 | 96,321 | 333,078 | ||||||||||||
| Face Value of Matured Policies | 27,470 | 7,973 | 80,927 | 50,100 | ||||||||||||
| TTM Benefits / Premiums5 | 164.9 | % | 135.8 | % | 164.9 | % | 135.8 | % | ||||||||
| (1) | Attributable to common shareholders |
| (2) | Per basic and fully diluted share outstanding |
| (3) | Includes cash, restricted cash and policy benefits receivable |
| (4) | Face amount of policy benefits |
| (5) | The ratio of policy benefits realized to premiums paid on a trailing twelve month (TTM) basis |
| 2. | Revenue and Expense Discussion |
Third Quarter 2019 vs. Third Quarter 2018:
| · | Total revenue was $22.2 million in the current period, compared to $20.9 million in the year ago period primarily due to: |
| o | Net revenue recognized at matured policy event was $14.3 million higher, unrealized gain on acquisition was $8.5 million lower (as a result of lower life insurance purchases) and change in estimated probabilistic cash flows net of premium and fees was $3.6 million lower. |
| o | Net interest income on our commercial loan, exchange note, and Liquid Trust note was $0.6 million lower. |
| o | Other interest income decreased $0.2 million. |
| · | Total expenses were $43.6 million in the current period, compared to $31.5 million in the year ago period primarily due to: |
| o | Interest and fees increased by $6.5 million. This change was driven by increased interest on L Bonds of $5.2 million as a result of additional amounts outstanding, increased interest on Seller Trust L Bonds of $2.6 million which were outstanding the entire third quarter of 2019 versus a partial quarter in the year ago period, and partially offset by a decrease in interest on our senior credit facility of $1.3 million. |
| o | Operating expenses increased by $5.6 million. Compensation and professional expenses increased by $3.6 million and $1.2 million, respectively, primarily resulting from performance share unit expense and retention incentives associated with the Purchase and Contribution transaction (the strategic transaction with The Beneficient Company Group, L.P. (Beneficient) which occurred in April 2019), as well as increases in legal, audit and other professional fees. Other expenses also increased by $0.8 million due to increases in contract labor, IT expense, travel, and business insurance (also largely driven by the Purchase and Contribution transaction with Beneficient). |
2
Third Quarter Year to Date 2019 vs. Third Quarter Year to Date 2018:
| · | Total revenue was $71.4 million in the current period, compared to $59.8 million in the year ago period primarily due to: |
| o | Net revenue recognized at matured policy event was $29.1 million higher, charges on life expectancy updates were $4.9 million lower, unrealized gain on acquisition was $15.0 million lower (as a result of lower life insurance purchases), and a change in estimated probabilistic cash flows net of premiums and fees and change in life expectancy was $12.7 million lower as compared to the year ago period. |
| o | Interest income from the commercial loan, exchangeable note, and Liquid Trust promissory note increased $5.4 million and other income decreased $0.1 million. |
| · | Total expenses were $127.4 million in the current period, compared to $79.6 million in the year ago period primarily due to: |
| o | Interest and fees increased by $28.7 million year over year. Outstanding L Bonds increased over this time period resulting in $16.6 million of additional interest expense, Seller Trust L Bonds, which were issued in August 2018, increased interest expense by $16.4 million and senior credit facility interest decreased by $4.3 million. |
| o | Operating expenses increased by $19.1 million. Compensation and professional expenses increased by $8.6 million and $6.5 million, respectively, primarily resulting from performance share unit expense and retention incentives associated with the Purchase and Contribution transaction, as well as increases in legal and professional fees. Other expenses also increased by $4.0 million primarily driven by an increase in business insurance purchased in connection with the Purchase and Contribution transaction with Beneficient. |
| 3. | Life Insurance Portfolio Statistics |
Portfolio Summary:
| Total life insurance portfolio face value of policy benefits | $ | 2,064,156,000 | ||
| Average face value per policy | $ | 1,758,000 | ||
| Average face value per insured life | $ | 1,887,000 | ||
| Average age of insured (years)* | 82.3 | |||
| Average life expectancy estimate (years)* | 7.3 | |||
| Total number of policies | 1,174 | |||
| Number of unique lives | 1,094 | |||
| Demographics | 74% Male; 26% Female | |||
| Number of smokers | 45 | |||
| Largest policy as % of total portfolio face value | 0.64 | % | ||
| Average policy as % of total portfolio face value | 0.09 | % | ||
| Average annual premium as % of face value | 3.2 | % |
| * | Averages presented in the table are weighted averages. |
Distribution of Policies and Benefits by Current Age of Insured:
| Percentage of Total | ||||||||||||||||||||||||||
| Min Age | Max Age | Number of Policies | Policy Benefits | Number of Policies | Policy Benefits | Wtd. Avg. LE (Years) | ||||||||||||||||||||
| 95 | 101 | 18 | $ | 36,052,000 | 1.5 | % | 1.8 | % | 2.2 | |||||||||||||||||
| 90 | 94 | 145 | 284,908,000 | 12.4 | % | 13.8 | % | 3.3 | ||||||||||||||||||
| 85 | 89 | 249 | 587,733,000 | 21.2 | % | 28.5 | % | 5.1 | ||||||||||||||||||
| 80 | 84 | 251 | 456,526,000 | 21.4 | % | 22.1 | % | 7.9 | ||||||||||||||||||
| 75 | 79 | 223 | 341,449,000 | 19.0 | % | 16.5 | % | 9.8 | ||||||||||||||||||
| 70 | 74 | 214 | 284,739,000 | 18.2 | % | 13.8 | % | 11.1 | ||||||||||||||||||
| 60 | 69 | 74 | 72,749,000 | 6.3 | % | 3.5 | % | 11.6 | ||||||||||||||||||
| Total | 1,174 | $ | 2,064,156,000 | 100.0 | % | 100.0 | % | 7.3 | ||||||||||||||||||
3
| 4. | Life Insurance Policy Originations |
Life Insurance Portfolio Activity:
Three Months Ended September 30 | Nine Months Ended September 30 | |||||||||||||||
| 2019 | 2018 | 2019 | 2018 | |||||||||||||
| Total policy benefits purchased | $ | 3,155,000 | $ | 120,430,000 | $ | 96,321,000 | $ | 333,078,000 | ||||||||
| Life insurance policies purchased | 6 | 89 | 81 | 233 | ||||||||||||
| Average policy benefit purchased | $ | 526,000 | $ | 1,353,000 | $ | 1,189,000 | $ | 1,430,000 | ||||||||
| Direct policy benefits purchased | $ | 1,305,000 | $ | 16,524,000 | $ | 19,397,000 | $ | 29,561,000 | ||||||||
| Direct insurance policies purchased | 3 | 17 | 27 | 39 | ||||||||||||
| 5. | Additional Information |
Gain (Loss) on Life Insurance Policies:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| 2019 | 2018 | 2019 | 2018 | |||||||||||||
| Change in estimated probabilistic cash flows(1) | $ | 17,908,000 | $ | 19,069,000 | $ | 52,161,000 | $ | 55,483,000 | ||||||||
| Unrealized gain on acquisitions(2) | 472,000 | 9,021,000 | 6,775,000 | 21,790,000 | ||||||||||||
| Premiums and other annual fees | (17,219,000 | ) | (14,765,000 | ) | (49,000,000 | ) | (39,670,000 | ) | ||||||||
| Change in discount rates(3),(4) | — | — | — | — | ||||||||||||
| Change in life expectancy evaluation(5) | — | 73,000 | — | (4,890,000 | ) | |||||||||||
| Face value of matured policies | 27,470,000 | 7,973,000 | 80,927,000 | 50,100,000 | ||||||||||||
| Fair value of matured policies | (10,839,000 | ) | (5,650,000 | ) | (31,590,000 | ) | (29,883,000 | ) | ||||||||
| Gain (loss) on life insurance policies, net | $ | 17,792,000 | $ | 15,721,000 | $ | 59,273,000 | $ | 52,930,000 | ||||||||
| (1) | Change in fair value of expected future cash flows relating to our investment in life insurance policies that are not specifically attributable to changes in life expectancy, discount rate changes or policy maturity events. |
| (2) | Gain resulting from fair value in excess of the purchase price for life insurance policies acquired during the reporting period. |
| (3) | The discount rate applied to estimate the fair value of the portfolio of life insurance policies we own was 8.25% at each quarter end in 2019 and at December 31, 2018. This discount rate was 10.45% at September 30, 2018 and December 31, 2017. |
| (4) | The discount rate of 8.25% is based on our “longest life expectancy” methodology (among other factors) which was adopted at December 31, 2018, whereas the discount rate of 10.45% is based on our historical “average life expectancy methodology” (among other factors). See our 2018 Form 10-K filed on July 9, 2019 with Securities and Exchange Commission for additional information. |
| (5) | The change in fair value due to updating life expectancy estimates on certain life insurance policies in our portfolio. |
4
Policy Benefits Realized and Premiums Paid (TTM):
| Quarter End Date | Portfolio Face Amount ($) | 12-Month Trailing Benefits Realized ($) | 12-Month Trailing Premiums Paid ($) | 12-Month Trailing Benefits/Premium Coverage Ratio | ||||||||||||
| September 30, 2015 | 878,882,000 | 44,482,000 | 25,313,000 | 175.7 | % | |||||||||||
| December 31, 2015 | 944,844,000 | 31,232,000 | 26,650,000 | 117.2 | % | |||||||||||
| March 31, 2016 | 1,027,821,000 | 21,845,000 | 28,771,000 | 75.9 | % | |||||||||||
| June 30, 2016 | 1,154,798,000 | 30,924,000 | 31,891,000 | 97.0 | % | |||||||||||
| September 30, 2016 | 1,272,078,000 | 35,867,000 | 37,055,000 | 96.8 | % | |||||||||||
| December 31, 2016 | 1,361,675,000 | 48,452,000 | 40,239,000 | 120.4 | % | |||||||||||
| March 31, 2017 | 1,447,558,000 | 48,189,000 | 42,753,000 | 112.7 | % | |||||||||||
| June 30, 2017 | 1,525,363,000 | 49,295,000 | 45,414,000 | 108.5 | % | |||||||||||
| September 30, 2017 | 1,622,627,000 | 53,742,000 | 46,559,000 | 115.4 | % | |||||||||||
| December 31, 2017 | 1,676,148,000 | 64,719,000 | 52,263,000 | 123.8 | % | |||||||||||
| March 31, 2018 | 1,758,066,000 | 60,248,000 | 53,169,000 | 113.3 | % | |||||||||||
| June 30, 2018 | 1,849,079,000 | 76,936,000 | 53,886,000 | 142.8 | % | |||||||||||
| September 30, 2018 | 1,961,598,000 | 75,161,000 | 55,365,000 | 135.8 | % | |||||||||||
| December 31, 2018 | 2,047,992,000 | 71,090,000 | 52,675,000 | 135.0 | % | |||||||||||
| March 31, 2019 | 2,098,428,000 | 87,045,000 | 56,227,000 | 154.8 | % | |||||||||||
| June 30, 2019 | 2,088,445,000 | 82,421,000 | 59,454,000 | 138.6 | % | |||||||||||
| September 30, 2019 | 2,064,156,000 | 101,918,000 | 61,805,000 | 164.9 | % | |||||||||||
Webcast/Conference Call Details
Management will host a webcast/conference call Thursday, November 21 at 4:30 p.m. EST to discuss our financial and operating results. The webcast will give viewers audio and access to PowerPoint slides that illustrate points made during the call. To register for the call and webcast, go to http://get.gwgh.com/q32019webcastinvite.
After the webcast is completed, a replay of it can be accessed at http://get.gwgh.com/q32019webcast.
About GWG Holdings, Inc.
GWG Holdings, Inc. (Nasdaq: GWGH), a financial services holding company committed to transforming the alternative asset industry through innovative liquidity products and related services for the owners of illiquid alternative investments, is the parent company of GWG Life which owns a portfolio of $2.06 billion in face value of life insurance policy benefits as of September 30, 2019. GWGH has executed a series of strategic transactions with The Beneficient Company Group, L.P., a financial services company providing proprietary liquidity solutions to owners of alternative assets, resulting in the closer alignment of the two companies. This alignment includes changing a number of GWGH management and the board of directors with Beneficient management, directors and affiliated parties. GWGH has also created an independent, special committee of the GWGH board of directors. GWGH’s subsidiary InsurTech Holdings, LLC, owns two companies exploring business applications for the emerging science of epigenetics: Life Epigenetics which is working to commercialize epigenetic technology for the life insurance and related industries; and YouSurance, a digital life insurance agency whose goal is to use epigenetic testing to support health and wellness while reducing the cost of insurance.
For more information about GWG Holdings, email info@gwgh.com or visit www.gwgh.com.
5
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans and objectives of management are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “would,” “target” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements include, among other things, statements about our estimates regarding future revenue and financial performance. We may not actually achieve the expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the expectations disclosed in the forward-looking statements that we make. More information about potential factors that could affect our business and financial results is contained in our filings with the Securities and Exchange Commission. Additional information will also be set forth in our future quarterly reports on Form 10-Q, annual reports on Form 10-K and other filings that we make with the Securities and Exchange Commission. We do not intend, and undertake no duty, to release publicly any updates or revisions to any forward-looking statements contained herein.
Media Contact:
Dan Callahan
Director of Communication
GWG Holdings, Inc.
(612) 746-1935
dcallahan@gwgh.com
6
GWG HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
| September 30, 2019 (unaudited) | December 31, 2018 | |||||||
| ASSETS | ||||||||
| Cash and cash equivalents | $ | 65,680,464 | $ | 114,587,084 | ||||
| Restricted cash | 8,204,705 | 10,849,126 | ||||||
| Investment in life insurance policies, at fair value | 807,518,088 | 747,922,465 | ||||||
| Life insurance policy benefits receivable, net | 17,369,176 | 16,460,687 | ||||||
| Financing receivables from affiliates | 241,185,081 | 184,768,874 | ||||||
| Equity method investment | 370,652,128 | 360,841,651 | ||||||
| Other assets | 50,391,311 | 45,437,164 | ||||||
| TOTAL ASSETS | $ | 1,561,000,953 | $ | 1,480,867,051 | ||||
| LIABILITIES & STOCKHOLDERS’ EQUITY | ||||||||
| LIABILITIES | ||||||||
| Senior credit facility with LNV Corporation | $ | 131,717,520 | $ | 148,977,596 | ||||
| L Bonds | 830,341,949 | 651,402,663 | ||||||
| Seller Trust L Bonds | 366,891,940 | 366,891,940 | ||||||
| Accounts payable | 2,570,842 | 9,276,507 | ||||||
| Interest and dividends payable | 16,726,344 | 18,555,293 | ||||||
| Other accrued expenses | 6,700,336 | 4,705,170 | ||||||
| TOTAL LIABILITIES | 1,354,948,931 | 1,199,809,169 | ||||||
| STOCKHOLDERS’ EQUITY | ||||||||
| REDEEMABLE PREFERRED STOCK | ||||||||
| (par value $0.001; shares authorized 100,000; shares outstanding 92,124 and 97,524; liquidation preference of $92,661,000 and $98,093,000 as of September 30, 2019 and December 31, 2018, respectively) | 81,509,765 | 86,910,335 | ||||||
| SERIES 2 REDEEMABLE PREFERRED STOCK | ||||||||
| (par value $0.001; shares authorized 150,000; shares outstanding 147,604 and 148,359; liquidation preference of $148,465,000 and $149,225,000 as of September 30, 2019 and December 31, 2018, respectively) | 128,307,735 | 129,062,704 | ||||||
| COMMON STOCK | ||||||||
| (par value $0.001; shares authorized 210,000,000; shares issued and outstanding 33,033,420 as of September 30, 2019 and 33,018,161 as of December 31, 2018) | 33,033 | 33,018 | ||||||
| Additional paid-in capital | 237,159,909 | 249,662,168 | ||||||
| Accumulated deficit | (240,958,420 | ) | (184,610,343 | ) | ||||
| TOTAL STOCKHOLDERS’ EQUITY | 206,052,022 | 281,057,882 | ||||||
| TOTAL LIABILITIES & EQUITY | $ | 1,561,000,953 | $ | 1,480,867,051 | ||||
7
GWG HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 30, 2019 | September 30, 2018 | September 30, 2019 | September 30, 2018 | |||||||||||||
| REVENUE | ||||||||||||||||
| Gain (loss) on life insurance policies, net | $ | 17,792,324 | $ | 15,721,513 | $ | 59,218,532 | $ | 52,930,008 | ||||||||
| Interest and other income | 4,418,655 | 5,215,515 | 12,219,762 | 6,863,640 | ||||||||||||
| TOTAL REVENUE | 22,210,979 | 20,937,028 | 71,438,294 | 59,793,648 | ||||||||||||
| EXPENSES | ||||||||||||||||
| Interest expense | 28,289,670 | 21,799,332 | 83,751,611 | 55,010,519 | ||||||||||||
| Employee compensation and benefits | 9,136,824 | 5,548,771 | 21,084,815 | 12,527,139 | ||||||||||||
| Legal and professional fees | 2,594,467 | 1,421,964 | 10,263,230 | 3,751,321 | ||||||||||||
| Other expenses | 3,549,265 | 2,688,970 | 12,315,434 | 8,262,324 | ||||||||||||
| TOTAL EXPENSES | 43,570,226 | 31,459,037 | 127,415,090 | 79,551,303 | ||||||||||||
| INCOME (LOSS) BEFORE INCOME TAXES | (21,359,247 | ) | (10,522,009 | ) | (55,976,796 | ) | (19,757,655 | ) | ||||||||
| INCOME TAX EXPENSE (BENEFIT) | — | — | — | — | ||||||||||||
| NET INCOME (LOSS) BEFORE EARNINGS (LOSS) FROM EQUITY METHOD INVESTMENT | (21,359,247 | ) | (10,522,009 | ) | (55,976,796 | ) | (19,757,655 | ) | ||||||||
| Earnings (loss) from equity method investment | 955,751 | — | (371,281 | ) | ||||||||||||
| NET INCOME (LOSS) | (20,403,496 | ) | (10,522,009 | ) | (56,348,077 | ) | (19,757,655 | ) | ||||||||
| Preferred stock dividends | 4,231,641 | 4,313,542 | 12,806,173 | 12,356,513 | ||||||||||||
| NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS | $ | (24,635,137 | ) | $ | (14,835,551 | ) | $ | (69,154,250 | ) | $ | (32,114,168 | ) | ||||
| NET INCOME (LOSS) PER COMMON SHARE | ||||||||||||||||
| Basic | $ | (0.75 | ) | $ | (2.52 | ) | $ | (2.09 | ) | $ | (5.50 | ) | ||||
| Diluted | $ | (0.75 | ) | $ | (2.52 | ) | $ | (2.09 | ) | $ | (5.50 | ) | ||||
| WEIGHTED AVERAGE COMMON SHARES OUTSTANDING | ||||||||||||||||
| Basic | 33,033,420 | 5,894,639 | 33,010,100 | 5,840,880 | ||||||||||||
| Diluted | 33,033,420 | 5,894,639 | 33,010,100 | 5,840,880 | ||||||||||||
8